FINAL RESULTS OF A MULTICENTRE PHASE II TRIAL EVALUATING CETUXIMAB IN COMBINATION WITH FOLFIRINOX AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS

被引：0
|
作者：
Samalin, E. [1 ]
Desseigne, F. [2 ]
Thezenas, S. [1 ]
Bibeau, F. [1 ]
Viret, F. [3 ]
Mineur, L. [4 ]
Assenat, E. [1 ]
Bleuse, J. [1 ]
Portales, F. [1 ]
Crapez, E. [1 ]
Ychou, M. [1 ]
机构：
[1] CRLC Val Aurelle, Montpellier, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Inst J Paoli I Calmettes, F-13009 Marseille, France
[4] Inst St Catherine, Avignon, France
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [1] LONG TERM RESULTS OF A MULTICENTRE PHASE II TRIAL ASSESSING CETUXIMAB IN COMBINATION WITH FOLFIRINOX AS FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS ACCORDING TO KRAS STATUS
    Samalin, E.
    Francoise, D.
    Thezenas, S.
    Bibeau, F.
    Viret, F.
    Mineur, L.
    Assenat, E.
    Bleuse, J.
    Portales, F.
    Crapez, E.
    Ychou, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 23 - 23
  • [2] Interim analysis of a multicentre phase II trial evaluating cetuximab in combination with folfirinox (LV5FU+CPT-11+LOHP) as first line treatment of metastatic colorectal cancer (MCRC) patients
    Samalin, E.
    Thezenas, S.
    Mineur, L.
    Viret, F.
    Assenat, E.
    Senesse, P.
    Bleuse, J.
    Kramar, A.
    Ychou, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [3] Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial
    Assenat, Eric
    Desseigne, Francoise
    Thezenas, Simon
    Viret, Frederic
    Mineur, Laurent
    Kramar, Andrew
    Samalin, Emmanuelle
    Portales, Fabienne
    Bibeau, Frederic
    Crapez-Lopez, Evelyne
    Bleuse, Jean Pierre
    Ychou, Marc
    ONCOLOGIST, 2011, 16 (11): : 1557 - 1564
  • [4] Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
    Tabernero, Josep
    Van Cutsem, Eric
    Diaz-Rubio, Eduardo
    Cervantes, Andres
    Humblet, Yves
    Andre, Thierry
    Van Laethem, Jean-Luc
    Soulie, Patrick
    Casado, Esther
    Verslype, Chris
    Valera, Javier Sastre
    Tortora, Giampaolo
    Ciardiello, Fortunato
    Kisker, Oliver
    de Gramont, Aimery
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5225 - 5232
  • [5] Cetuximab and capecitabine as first-line treatment for elderly patients (pts) with metastatic colorectal cancer (mCRC): Preliminary results of TTD trial
    Gravalos, C.
    Rivera, F.
    Massuti, B.
    Sastre, J.
    Marcuello, E.
    Valladares, M.
    Gil, S.
    Abad, A.
    Diaz-Rubio, E.
    Aranda, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer
    Boccia, Ralph V.
    Cosgriff, Thomas M.
    Headley, David L.
    Badarinath, Suprith
    Dakhil, Shaker R.
    CLINICAL COLORECTAL CANCER, 2010, 9 (02) : 102 - 107
  • [7] Results of a phase II trial of cetuximab plus XELIRI as first-line therapy of patients with advanced and/or metastatic colorectal cancer
    Cartwright, T. H.
    Kuefler, P.
    Cohn, A.
    Hyman, W.
    Yoffe, M.
    Boehm, K. A.
    Ilegbodu, D.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] CETUFTIRI, a new combination of UFT with leucovorin (LV), irinotecan, and cetuximab as first-line treatment for patients (pts) with unresectable metastatic colorectal cancer (mCRC): Preliminary results from a multicenter phase II trial
    Bennouna, J.
    Faroux, R.
    Francois, E.
    Ligeza, C.
    El Hannani, C.
    Perrier, H.
    Jacob, J.
    Desseigne, F.
    Perrocheau, G.
    Douillard, J. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] EFFICACY AND SAFETY OF CETUXIMAB, OXALIPLATIN AND CAPECITABINE AS FIRST-LINE THERAPY FOR METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A PHASE II STUDY
    Barroso, S.
    Sanches, E.
    Ferreira, J.
    Passos, M.
    Sa, A.
    Nabico, R.
    SottoMayor, C.
    Santo, Espirito J.
    San-Bento, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 65 - 65
  • [10] Efficacy and safety of cetuximab, oxaliplatin, and capecitabine as first-line therapy for metastatic colorectal cancer (mCRC): Results of a phase II study
    Barroso, S. A.
    Sanches, E.
    Ferreira, M.
    Passos, M.
    Sa, A.
    Nabico, R.
    Sotto-Mayor, C.
    Santo, J. Espirito
    San-Bento, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345